Exploratory Tympanotomy Laboratory Medicine

1. Sourdille M. New Technique in the Surgical Treatment of Severe and Progressive Deafness from Otosclerosis. Bull N Y Acad Med. 1937 Dec. 13(12):673-91. [Medline].

2. Lempert J. Improvement of hearing in cases of otosclerosis. Arch Otolaryngol. 1938. 28:42-97.

3. Rosen S. Palpation of stapes for fixation; preliminary procedure to determine fenestration suitability in otosclerosis. AMA Arch Otolaryngol. 1952 Dec. 56(6):610-5. [Medline].

4. Paparella MM, Koutroupas S. Exploratory tympanotomy revisited. Laryngoscope. 1982 May. 92(5):531-4. [Medline].

5. Robertson G, Mills R. Findings at exploratory tympanotomy for conductive hearing loss. J Laryngol Otol. 2009 Oct. 123(10):1087-9. [Medline].

6. Basson OJ, van Lierop AC. Conductive hearing loss after head trauma: review of ossicular pathology, management and outcomes. J Laryngol Otol. 2009 Feb. 123(2):177-81. [Medline].

Matthew Ng, MD Clinical Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Keck School of Medicine of the University of Southern California; Clinical Assistant Professor, Department of Surgery, Division of Otolaryngology, University of Nevada School of Medicine

Matthew Ng, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Association for the Advancement of Science, American College of Surgeons, North American Skull Base Society, Society of University Otolaryngologists-Head and Neck Surgeons, Vestibular Disorders Association, Johns Hopkins Medical and Surgical Association, The Triological Society, Association for Research in Otolaryngology

Disclosure: Nothing to disclose.

Arlen D Meyers, MD, MBA Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cerescan;RxRevu;Cliexa;Preacute Population Health Management;The Physicians Edge<br/>Received income in an amount equal to or greater than $250 from: The Physicians Edge, Cliexa<br/> Received stock from RxRevu; Received ownership interest from Cerescan for consulting; .

• Print this section
• Print the entire contents of